Paul Hartmann AG
PHH2
ISIN DE0007474041 / Valor 1547181
Paul Hartmann AG
UMushroom community rating:
About company
Paul Hartmann AG is a German company with a long history in the healthcare sector, specializing in the production and distribution of medical and hygiene products. Originally established as a textile business in the late 18th century, the company transitioned into the healthcare industry in the 1870s. Today, Hartmann is recognized for its comprehensive range of products, including wound management solutions, incontinence care, and infection prevention products. The company serves a global market, providing essential medical supplies to hospitals, healthcare professionals, and consumers. With a focus on innovation and quality, Hartmann continues to expand its product offerings to meet the evolving needs of the healthcare industry.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (20.05.2026):
Paul Hartmann AG — Q4 2025 (reporting on the 2025 financial year): The company’s own preliminary results show organic sales growth of 2.2% for 2025 and preliminary adjusted EBITDA of EUR 277 million (about EUR 15 million above the prior year), with an improvement in the EBITDA margin of roughly 0.3 percentage points. These are preliminary HARTMANN GROUP figures reported on 3 February 2026.
Sales
Preliminary organic sales growth for the 2025 financial year was 2.2% according to the company’s report.
Adjusted EBITDA
Preliminary adjusted EBITDA was reported at EUR 277 million, approximately EUR 15 million higher than the previous year; the adjusted EBITDA margin improved by about 0.3 percentage points.
Drivers
The report attributes improved profitability to the company's Transformation Program, new product launches, cost measures and new customer-oriented solutions despite declines in some core markets.
Outlook and timing
A progressive forecast for 2026 and the full audited financial results for 2025 will be published on 19 March 2026.
Business scope
The report reiterates HARTMANN GROUP’s market position as a leading European provider of professional medical and care products across Incontinence Management, Wound Care and Infection Management, with sales in 130 countries.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
853 M
Market cap (USD)
Daily traded volume (Shares)
222 / 222
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
